A
Ankon Medical Technologies
Wuhan magnetically controlled capsule gastroscopy (NaviCam)
About Ankon Medical Technologies
Ankon Medical Technologies, established in 2008, operates within the gastrointestinal health sector, focusing on the development and commercialization of medical devices for digestive disease screening and diagnosis. The company was co-founded by Ji Xiao, who brings a background in Silicon Valley's optical and semiconductor industries, alongside CTO Zuo Qiang and Chief Scientist Duan Xiaodong. Ankon has achieved significant milestones, including securing China's first CFDA approval for a capsule gastroscope in 2013 and raising over $100 million in a 2017 funding round. The firm's core business revolves around its NaviCam capsule endoscopy system. This product is a magnetically controlled robotic capsule that, once swallowed, allows physicians to non-invasively and comfortably examine the stomach and upper gastrointestinal tract. The system provides an alternative to traditional, more invasive gastroscopy procedures, targeting patients and medical institutions seeking less discomfort and greater precision in early-stage cancer detection and other digestive health diagnostics. Ankon generates revenue through the sale of these capsule systems and associated equipment to hospitals and clinics. The company serves the Chinese domestic market and has expanded its presence internationally, obtaining CE marking in Europe and clearance in other regions. Its business model is based on providing a complete hardware and software solution for gastrointestinal examination, positioning itself as a key player in the preventative health and medical device market.
Source: Dealroom company dataNews
Open roles
Ankon Medical Technologies in the Wuhan ecosystem
The Ankon Medical Technologies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
SB China Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
429 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Ankon Medical Technologies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Ankon Medical Technologies on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


